Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X about recent review by Dustin Deming, Associate Professor of Hematology, Medical Oncology and Palliative Care at University of Wisconsin department of medicine, published in JNCCN:
“KRAS inhibitors and mCRC.
Excellent review right on time.
Tolerability and efficacy of monotherapy and combinations.
The ones under investigation.”
“Development of KRAS Inhibitors and Their Role for Metastatic Colorectal Cancer”
Author: Dustin Deming
More posts featuring Erman Akkus.
